172 related articles for article (PubMed ID: 34022460)
1. Histone lysine methyltransferase SET8 is a novel therapeutic target for cancer treatment.
Yang C; Wang K; Zhou Y; Zhang SL
Drug Discov Today; 2021 Oct; 26(10):2423-2430. PubMed ID: 34022460
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of histone methyltransferase SET8 inhibits progression of hepatocellular carcinoma.
Wu J; Qiao K; Du Y; Zhang X; Cheng H; Peng L; Guo Z
Sci Rep; 2020 Mar; 10(1):4490. PubMed ID: 32161353
[TBL] [Abstract][Full Text] [Related]
3. CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation.
Abbas T; Shibata E; Park J; Jha S; Karnani N; Dutta A
Mol Cell; 2010 Oct; 40(1):9-21. PubMed ID: 20932471
[TBL] [Abstract][Full Text] [Related]
4. Targeting histone lysine methylation in cancer.
McGrath J; Trojer P
Pharmacol Ther; 2015 Jun; 150():1-22. PubMed ID: 25578037
[TBL] [Abstract][Full Text] [Related]
5. microRNA-7 suppresses the invasive potential of breast cancer cells and sensitizes cells to DNA damages by targeting histone methyltransferase SET8.
Yu N; Huangyang P; Yang X; Han X; Yan R; Jia H; Shang Y; Sun L
J Biol Chem; 2013 Jul; 288(27):19633-42. PubMed ID: 23720754
[TBL] [Abstract][Full Text] [Related]
6. Purification and functional characterization of SET8, a nucleosomal histone H4-lysine 20-specific methyltransferase.
Fang J; Feng Q; Ketel CS; Wang H; Cao R; Xia L; Erdjument-Bromage H; Tempst P; Simon JA; Zhang Y
Curr Biol; 2002 Jul; 12(13):1086-99. PubMed ID: 12121615
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of nucleosomal histone H4 lysine 20 methylation by SET8 methyltransferase.
Ho CH; Takizawa Y; Kobayashi W; Arimura Y; Kimura H; Kurumizaka H
Life Sci Alliance; 2021 Apr; 4(4):. PubMed ID: 33574035
[TBL] [Abstract][Full Text] [Related]
8. The microtubule-associated histone methyltransferase SET8, facilitated by transcription factor LSF, methylates α-tubulin.
Chin HG; Esteve PO; Ruse C; Lee J; Schaus SE; Pradhan S; Hansen U
J Biol Chem; 2020 Apr; 295(14):4748-4759. PubMed ID: 32111740
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin-specific protease USP17 prevents cellular senescence by stabilizing the methyltransferase SET8 and transcriptionally repressing
Fukuura K; Inoue Y; Miyajima C; Watanabe S; Tokugawa M; Morishita D; Ohoka N; Komada M; Hayashi H
J Biol Chem; 2019 Nov; 294(44):16429-16439. PubMed ID: 31533987
[TBL] [Abstract][Full Text] [Related]
10. Progress in the Development of Lysine Methyltransferase SETD8 Inhibitors.
Milite C; Feoli A; Viviano M; Rescigno D; Mai A; Castellano S; Sbardella G
ChemMedChem; 2016 Aug; 11(16):1680-5. PubMed ID: 27411844
[TBL] [Abstract][Full Text] [Related]
11. The SET8 H4K20 protein lysine methyltransferase has a long recognition sequence covering seven amino acid residues.
Kudithipudi S; Dhayalan A; Kebede AF; Jeltsch A
Biochimie; 2012 Nov; 94(11):2212-8. PubMed ID: 22583696
[TBL] [Abstract][Full Text] [Related]
12. Direct interaction between SET8 and proliferating cell nuclear antigen couples H4-K20 methylation with DNA replication.
Huen MS; Sy SM; van Deursen JM; Chen J
J Biol Chem; 2008 Apr; 283(17):11073-7. PubMed ID: 18319261
[TBL] [Abstract][Full Text] [Related]
13. Histone H4 Lys 20 methyltransferase SET8 promotes androgen receptor-mediated transcription activation in prostate cancer.
Yao L; Li Y; Du F; Han X; Li X; Niu Y; Ren S; Sun Y
Biochem Biophys Res Commun; 2014 Jul; 450(1):692-6. PubMed ID: 24937452
[TBL] [Abstract][Full Text] [Related]
14. Monomethyltransferase SET8 facilitates hepatocellular carcinoma growth by enhancing aerobic glycolysis.
Chen X; Ding X; Wu Q; Qi J; Zhu M; Miao C
Cell Death Dis; 2019 Apr; 10(4):312. PubMed ID: 30952833
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA XLOC_006390 promotes cervical cancer proliferation and metastasis through the regulation of SET domain containing 8.
Luan X; Wang Y
Oncol Rep; 2017 Jul; 38(1):159-166. PubMed ID: 28534991
[TBL] [Abstract][Full Text] [Related]
16. Modulation of p53 function by SET8-mediated methylation at lysine 382.
Shi X; Kachirskaia I; Yamaguchi H; West LE; Wen H; Wang EW; Dutta S; Appella E; Gozani O
Mol Cell; 2007 Aug; 27(4):636-46. PubMed ID: 17707234
[TBL] [Abstract][Full Text] [Related]
17. Proteome identification of proteins interacting with histone methyltransferase SET8.
Qin Y; Ouyang H; Liu J; Xie Y
Acta Biochim Biophys Sin (Shanghai); 2013 Apr; 45(4):303-8. PubMed ID: 23419719
[TBL] [Abstract][Full Text] [Related]
18. CRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase.
Centore RC; Havens CG; Manning AL; Li JM; Flynn RL; Tse A; Jin J; Dyson NJ; Walter JC; Zou L
Mol Cell; 2010 Oct; 40(1):22-33. PubMed ID: 20932472
[TBL] [Abstract][Full Text] [Related]
19. SET8 induces epithelial‑mesenchymal transition and enhances prostate cancer cell metastasis by cooperating with ZEB1.
Hou L; Li Q; Yu Y; Li M; Zhang D
Mol Med Rep; 2016 Feb; 13(2):1681-8. PubMed ID: 26717907
[TBL] [Abstract][Full Text] [Related]
20. SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities.
Yang F; Sun L; Li Q; Han X; Lei L; Zhang H; Shang Y
EMBO J; 2012 Jan; 31(1):110-23. PubMed ID: 21983900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
